Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Wall Street
Price Targets
DRREDDY Price Targets Summary
Dr Reddy's Laboratories Ltd
According to Wall Street analysts, the average 1-year price target for
DRREDDY
is 1 307.65 INR
with a low forecast of 950.41 INR and a high forecast of 1 680 INR.
Price Targets
Operating Income
Forecast
Operating Income Estimate
Dr Reddy's Laboratories Ltd
For the last 13 years the
compound annual growth rate for
Dr Reddy's Laboratories Ltd's operating income is
10%.
The projected
CAGR
for the next 3 years is
-1%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is DRREDDY's stock price target?
Price Target
1 307.65
INR
According to Wall Street analysts, the average 1-year price target for
DRREDDY
is 1 307.65 INR
with a low forecast of 950.41 INR and a high forecast of 1 680 INR.
What is Dr Reddy's Laboratories Ltd's Revenue forecast?
Projected CAGR
6%
For the last 13 years the
compound annual growth rate for
Dr Reddy's Laboratories Ltd's revenue is
10%.
The projected
CAGR
for the next 3 years is
6%.
What is Dr Reddy's Laboratories Ltd's Operating Income forecast?
Projected CAGR
-1%
For the last 13 years the
compound annual growth rate for
Dr Reddy's Laboratories Ltd's operating income is
10%.
The projected
CAGR
for the next 3 years is
-1%.
What is Dr Reddy's Laboratories Ltd's Net Income forecast?
Projected CAGR
3%
For the last 13 years the
compound annual growth rate for
Dr Reddy's Laboratories Ltd's net income is
12%.
The projected
CAGR
for the next 3 years is
3%.
You don't have any saved screeners yet
